Patents Assigned to Zacharon Pharmaceutical, Inc.
  • QUANTIFICATION OF NON-REDUCING END GLYCAN RESIDUAL COMPOUNDS
    Publication number: 20130217056
    Abstract: Provided herein are methods of diagnosing or monitoring the treatment of abnormal glycan accumulation or a disorder associated with abnormal glycan accumulation.
    Type: Application
    Filed: September 27, 2012
    Publication date: August 22, 2013
    Applicant: ZACHARON PHARMACEUTICALS, INC.
    Inventor: Zacharon Pharmaceuticals, Inc.
  • QUANTIFICATION OF NON-REDUCING END GLYCAN RESIDUAL COMPOUNDS
    Publication number: 20130149729
    Abstract: Provided herein are methods of diagnosing or monitoring the treatment of abnormal glycan accumulation or a disorder associated with abnormal glycan accumulation.
    Type: Application
    Filed: July 16, 2012
    Publication date: June 13, 2013
    Applicant: Zacharon Pharmaceuticals, Inc.
    Inventors: Brett E. Crawford, Jillian R. Brown, Charles A. Glass, Jim R. Beitel, Robin M. Jackman
  • GLYCOSAMINOGLYCAN INHIBITORS
    Publication number: 20120295890
    Abstract: Provided herein are chondroitin sulfate inhibitors, including modulators of glycosylation, and/or sulfation of galactose or N-acetyl galactosamine glycosaminoglycans.
    Type: Application
    Filed: December 28, 2010
    Publication date: November 22, 2012
    Applicant: Zacharon Pharmaceutical, Inc.
    Inventors: Brett E. Crawford, Charles A. Glass, Jillian R. Brown
  • Quantification of non-reducing end glycan residual compounds
    Patent number: 8232073
    Abstract: Provided herein are methods of diagnosing or monitoring the treatment of abnormal glycan accumulation or a disorder associated with abnormal glycan accumulation.
    Type: Grant
    Filed: December 29, 2009
    Date of Patent: July 31, 2012
    Assignee: Zacharon Pharmaceuticals, Inc.
    Inventors: Brett E. Crawford, Jillian R. Brown, Charles A. Glass, Jim R. Beitel, Robin M. Jackman
  • Polymer end group detection
    Patent number: 8183003
    Abstract: Provided herein are processes of detecting and quantifying the number of polymer end groups in a sample. In particular instances provided herein are processes of detecting.
    Type: Grant
    Filed: December 31, 2009
    Date of Patent: May 22, 2012
    Assignee: Zacharon Pharmaceuticals, Inc.
    Inventors: Brett E. Crawford, Jillian R Brown, Charles A. Glass
  • DETECTION OF OLIGOSACCHARIDES
    Publication number: 20120009616
    Abstract: Provided herein are processes for detecting oligosaccharides in a biological sample. In specific instances, the biological sample is provided from an individual suffering from a disorder associated with abnormal glycosaminoglycan accumulation.
    Type: Application
    Filed: December 31, 2009
    Publication date: January 12, 2012
    Applicant: Zacharon Pharmaceuticals Inc.
    Inventors: Brett E. Crawford, Jillian R. Brown, Charles A. Glass
  • POLYMER END GROUP DETECTION
    Publication number: 20110311988
    Abstract: Provided herein are processes of detecting and quantifying the number of polymer end groups in a sample. In particular instances provided herein are processes of detecting.
    Type: Application
    Filed: December 31, 2009
    Publication date: December 22, 2011
    Applicant: ZACHARON PHARMACEUTICALS, INC.
    Inventors: Brett E. Crawford, Jillian R. Brown, Charles A. Glass
  • GANGLIOSIDE BIOSYNTHESIS MODULATORS
    Publication number: 20100248365
    Abstract: Provided herein are ganglioside synthesis inhibitors, including modulators of ganglioside glycosylation.
    Type: Application
    Filed: March 29, 2010
    Publication date: September 30, 2010
    Applicant: ZACHARON PHARMACEUTICALS, INC.
    Inventors: Brett E. CRAWFORD, Charles A. GLASS, Jillian R. BROWN, Xiaomei BAI
  • DETECTION OF OLIGOSACCHARIDES
    Publication number: 20100184013
    Abstract: Provided herein are processes for detecting oligosaccharides in a biological sample. In specific instances, the biological sample is provided from an individual suffering from a disorder associated with abnormal glycosaminoglycan accumulation.
    Type: Application
    Filed: December 29, 2009
    Publication date: July 22, 2010
    Applicant: ZACHARON PHARMACEUTICALS, INC.
    Inventors: Brett E. CRAWFORD, Jillian R. BROWN, Charles A. GLASS
  • QUANTIFICATION OF NON-REDUCING END GLYCAN RESIDUAL COMPOUNDS
    Publication number: 20100173337
    Abstract: Provided herein are methods of diagnosing or monitoring the treatment of abnormal glycan accumulation or a disorder associated with abnormal glycan accumulation.
    Type: Application
    Filed: December 29, 2009
    Publication date: July 8, 2010
    Applicant: ZACHARON PHARMACEUTICALS, INC.
    Inventors: Brett E. CRAWFORD, Jillian R. BROWN, Charles A. GLASS, Jim R. BEITEL, Robin M. JACKMAN
  • HEPARAN SULFATE INHIBITORS
    Publication number: 20100048638
    Abstract: Provided herein are heparan sulfate inhibitors, including modulators of heparan sulfate glycosylation, heparan sulfate sulfation, and/or heparan sulfate epimerization.
    Type: Application
    Filed: July 1, 2009
    Publication date: February 25, 2010
    Applicant: ZACHARON PHARMACEUTICALS, INC.
    Inventors: Brett E. CRAWFORD, Charles A. GLASS, Jillian R. BROWN, Robert G. WITT, Benedikt VOLLRATH, Jay LICHTER